BTNL8, a butyrophilin-like molecule that costimulates the primary immune response

Andrei I. Chapoval(Human Genome Sciences (United States)), Peter Mézeš(North Bristol NHS Trust), Ferenc Boldog(Sepragen Corporation (United States)), Nikolai V. Khramtsov(Sepragen Corporation (United States)), Mehdi Mesri(National Cancer Institute), Linda Brunick(Sepragen Corporation (United States)), Glennda Smithson(Takeda (United States)), Elena A Feshchenko(Sepragen Corporation (United States)), David P. Andrew(Amgen (United States)), Gary C. Starling(Sepragen Corporation (United States))
Molecular Immunology
September 19, 2013
Cited by 42


Related Papers